Trials / Withdrawn
WithdrawnNCT03181087
Safety of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars
A Phase I, Single-arm, Open Study of the Safety of Umbilical Cord Mesenchymal Stem Cell Local Intramuscular Injection for Treatment of Uterine Scars
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Maternal and Child Health Hospital of Foshan · Academic / Other
- Sex
- Female
- Age
- 21 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety of umbilical cord mesenchymal stem cell local intramuscular injection for treatment of uterine scars by a prospective, single-center, open, and single-arm clinical trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Umbilical cord MSCs | Participants will receive direct local intramuscular injection of 1\*10\^7 MSCs (in 1ml of 0.9% saline) in the uterine incision. |
Timeline
- Start date
- 2021-12-11
- Primary completion
- 2022-10-31
- Completion
- 2023-05-30
- First posted
- 2017-06-08
- Last updated
- 2022-12-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03181087. Inclusion in this directory is not an endorsement.